News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ExonHit Therapeutics Inc. Receives € 1.93 Million from OSEO Within the Personalized Medicine TEDAC Project in Cancer


6/5/2012 10:32:56 AM

PARIS--(BUSINESS WIRE)--Regulatory News: Exonhit (Paris: ALEHT) announced today that it has been granted € 1,928,000 by OSEO, as part of its involvement in a consortium led by ERYTECH Pharma and funded under the program for "Strategic Industrial Innovation". € 1,126,000 were paid to Exonhit at the inception of the project during the first semester of 2012.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES